MedPath

Measuring Blood Pressure in Pregnancy Using Mercury and Automated Device

Not Applicable
Completed
Conditions
Hypertension
Pregnancy
Pre Eclampsia
Interventions
Device: Automated blood pressure recording device Omron HEM 705CP
Registration Number
NCT00809666
Lead Sponsor
St George Hospital, Australia
Brief Summary

The aim of the PRAM study was to determine whether women diagnosed with hypertension in pregnancy, using the traditional mercury device, have the same pregnancy outcomes when blood pressure is measured by either an automated device or a mercury device throughout the pregnancy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
220
Inclusion Criteria
  • women with a diagnosis of hypertension in pregnancy
Exclusion Criteria
  • non-pregnant and normotensive pregnancy women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MercuryAutomated blood pressure recording device Omron HEM 705CPAll subsequent blood pressure recording done using mercury sphygmomanometry
Primary Outcome Measures
NameTimeMethod
The primary maternal outcome measure was the number of women having any episode of severe hypertension (BP ³ 170/110mmHg).
Secondary Outcome Measures
NameTimeMethod
Secondary end points included gestation at birth, caesarean section and induction of labour rates.

Trial Locations

Locations (1)

St George Hospital

🇦🇺

Sydney, New South Wales, Australia

© Copyright 2025. All Rights Reserved by MedPath